Hypoxia induces gefitinib resistance in non‐small‐cell lung cancer with both mutant and wild‐type epidermal growth factor receptors

Somatic mutations in the epidermal growth factor receptor (EGFR) gene, such as exon 19 deletion mutations, are important factors in determining therapeutic responses to gefitinib in non‐small‐cell lung cancer (NSCLC). However, some patients have activating mutations in EGFR and show poor responses t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Minakata, Kunihiko, Takahashi, Fumiyuki, Nara, Takeshi, Hashimoto, Muneaki, Tajima, Ken, Murakami, Akiko, Nurwidya, Fariz, Yae, Suzu, Koizumi, Fumiaki, Moriyama, Hiroyuki, Seyama, Kuniaki, Nishio, Kazuto, Takahashi, Kazuhisa
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2012
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659171/
https://ncbi.nlm.nih.gov/pubmed/22863020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02408.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars